These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23792811)

  • 1. Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men.
    Killick E; Morgan R; Launchbury F; Bancroft E; Page E; Castro E; Kote-Jarai Z; Aprikian A; Blanco I; Clowes V; Domchek S; Douglas F; Eccles D; Evans DG; Harris M; Kirk J; Lam J; Lindeman G; Mitchell G; Pachter N; Selkirk C; Tucker K; Zgajnar J; Eeles R; Pandha H
    Sci Rep; 2013; 3():2059. PubMed ID: 23792811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancer.
    Morgan R; Boxall A; Bhatt A; Bailey M; Hindley R; Langley S; Whitaker HC; Neal DE; Ismail M; Whitaker H; Annels N; Michael A; Pandha H
    Clin Cancer Res; 2011 Mar; 17(5):1090-8. PubMed ID: 21364037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Engrailed-2 (EN2) a truly promising biomarker in prostate cancer detection?
    Do Carmo Silva J; Vesely S; Novak V; Luksanova H; Prusa R; Babjuk M
    Biomarkers; 2020 Feb; 25(1):34-39. PubMed ID: 31692391
    [No Abstract]   [Full Text] [Related]  

  • 4. EN2 in Prostate Cancer.
    McGrath SE; Michael A; Morgan R; Pandha H
    Adv Clin Chem; 2015; 71():47-76. PubMed ID: 26411411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary engrailed-2 (EN2) levels predict tumour volume in men undergoing radical prostatectomy for prostate cancer.
    Pandha H; Sorensen KD; Orntoft TF; Langley S; Hoyer S; Borre M; Morgan R
    BJU Int; 2012 Sep; 110(6 Pt B):E287-92. PubMed ID: 22583908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engrailed-2 protein as a potential urinary prostate cancer biomarker: a comparison study before and after digital rectal examination.
    Marszałł MP; Sroka W; Adamowski M; Słupski P; Jarzemski P; Siódmiak J; Odrowąż-Sypniewska G
    Eur J Cancer Prev; 2015 Jan; 24(1):51-6. PubMed ID: 25003607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.
    Page EC; Bancroft EK; Brook MN; Assel M; Hassan Al Battat M; Thomas S; Taylor N; Chamberlain A; Pope J; Raghallaigh HN; Evans DG; Rothwell J; Maehle L; Grindedal EM; James P; Mascarenhas L; McKinley J; Side L; Thomas T; van Asperen C; Vasen H; Kiemeney LA; Ringelberg J; Jensen TD; Osther PJS; Helfand BT; Genova E; Oldenburg RA; Cybulski C; Wokolorczyk D; Ong KR; Huber C; Lam J; Taylor L; Salinas M; Feliubadaló L; Oosterwijk JC; van Zelst-Stams W; Cook J; Rosario DJ; Domchek S; Powers J; Buys S; O'Toole K; Ausems MGEM; Schmutzler RK; Rhiem K; Izatt L; Tripathi V; Teixeira MR; Cardoso M; Foulkes WD; Aprikian A; van Randeraad H; Davidson R; Longmuir M; Ruijs MWG; Helderman van den Enden ATJM; Adank M; Williams R; Andrews L; Murphy DG; Halliday D; Walker L; Liljegren A; Carlsson S; Azzabi A; Jobson I; Morton C; Shackleton K; Snape K; Hanson H; Harris M; Tischkowitz M; Taylor A; Kirk J; Susman R; Chen-Shtoyerman R; Spigelman A; Pachter N; Ahmed M; Ramon Y Cajal T; Zgajnar J; Brewer C; Gadea N; Brady AF; van Os T; Gallagher D; Johannsson O; Donaldson A; Barwell J; Nicolai N; Friedman E; Obeid E; Greenhalgh L; Murthy V; Copakova L; Saya S; McGrath J; Cooke P; Rønlund K; Richardson K; Henderson A; Teo SH; Arun B; Kast K; Dias A; Aaronson NK; Ardern-Jones A; Bangma CH; Castro E; Dearnaley D; Eccles DM; Tricker K; Eyfjord J; Falconer A; Foster C; Gronberg H; Hamdy FC; Stefansdottir V; Khoo V; Lindeman GJ; Lubinski J; Axcrona K; Mikropoulos C; Mitra A; Moynihan C; Rennert G; Suri M; Wilson P; Dudderidge T; ; Offman J; Kote-Jarai Z; Vickers A; Lilja H; Eeles RA
    Eur Urol; 2019 Dec; 76(6):831-842. PubMed ID: 31537406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EN2: a novel prostate cancer biomarker.
    McGrath SE; Michael A; Morgan R; Pandha H
    Biomark Med; 2013 Dec; 7(6):893-901. PubMed ID: 24266821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.
    Bancroft EK; Page EC; Castro E; Lilja H; Vickers A; Sjoberg D; Assel M; Foster CS; Mitchell G; Drew K; Mæhle L; Axcrona K; Evans DG; Bulman B; Eccles D; McBride D; van Asperen C; Vasen H; Kiemeney LA; Ringelberg J; Cybulski C; Wokolorczyk D; Selkirk C; Hulick PJ; Bojesen A; Skytte AB; Lam J; Taylor L; Oldenburg R; Cremers R; Verhaegh G; van Zelst-Stams WA; Oosterwijk JC; Blanco I; Salinas M; Cook J; Rosario DJ; Buys S; Conner T; Ausems MG; Ong KR; Hoffman J; Domchek S; Powers J; Teixeira MR; Maia S; Foulkes WD; Taherian N; Ruijs M; Helderman-van den Enden AT; Izatt L; Davidson R; Adank MA; Walker L; Schmutzler R; Tucker K; Kirk J; Hodgson S; Harris M; Douglas F; Lindeman GJ; Zgajnar J; Tischkowitz M; Clowes VE; Susman R; Ramón y Cajal T; Patcher N; Gadea N; Spigelman A; van Os T; Liljegren A; Side L; Brewer C; Brady AF; Donaldson A; Stefansdottir V; Friedman E; Chen-Shtoyerman R; Amor DJ; Copakova L; Barwell J; Giri VN; Murthy V; Nicolai N; Teo SH; Greenhalgh L; Strom S; Henderson A; McGrath J; Gallagher D; Aaronson N; Ardern-Jones A; Bangma C; Dearnaley D; Costello P; Eyfjord J; Rothwell J; Falconer A; Gronberg H; Hamdy FC; Johannsson O; Khoo V; Kote-Jarai Z; Lubinski J; Axcrona U; Melia J; McKinley J; Mitra AV; Moynihan C; Rennert G; Suri M; Wilson P; Killick E; ; Moss S; Eeles RA
    Eur Urol; 2014 Sep; 66(3):489-99. PubMed ID: 24484606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary EN-2 to predict prostate cancer: Systematic review and meta-analysis.
    Rosa MID; Dondossola ER; Alexandre MCM; Madeira K; Cardoso FA; Grande AJ
    Rev Assoc Med Bras (1992); 2017 Jul; 63(7):656-661. PubMed ID: 28977093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study.
    Mitra AV; Bancroft EK; Barbachano Y; Page EC; Foster CS; Jameson C; Mitchell G; Lindeman GJ; Stapleton A; Suthers G; Evans DG; Cruger D; Blanco I; Mercer C; Kirk J; Maehle L; Hodgson S; Walker L; Izatt L; Douglas F; Tucker K; Dorkins H; Clowes V; Male A; Donaldson A; Brewer C; Doherty R; Bulman B; Osther PJ; Salinas M; Eccles D; Axcrona K; Jobson I; Newcombe B; Cybulski C; Rubinstein WS; Buys S; Townshend S; Friedman E; Domchek S; Ramon Y Cajal T; Spigelman A; Teo SH; Nicolai N; Aaronson N; Ardern-Jones A; Bangma C; Dearnaley D; Eyfjord J; Falconer A; Grönberg H; Hamdy F; Johannsson O; Khoo V; Kote-Jarai Z; Lilja H; Lubinski J; Melia J; Moynihan C; Peock S; Rennert G; Schröder F; Sibley P; Suri M; Wilson P; Bignon YJ; Strom S; Tischkowitz M; Liljegren A; Ilencikova D; Abele A; Kyriacou K; van Asperen C; Kiemeney L; ; Easton DF; Eeles RA
    BJU Int; 2011 Jan; 107(1):28-39. PubMed ID: 20840664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel sensitive immunosensor for the selective detection of Engrailed 2 urinary prostate cancer biomarker.
    Mokni M; Tlili A; Attia G; Khaoulani S; Zerrouki C; Omezzine A; Othmane A; Bouslama A; Fourati N
    Biosens Bioelectron; 2022 Dec; 217():114678. PubMed ID: 36116221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers.
    Cremers RG; Eeles RA; Bancroft EK; Ringelberg-Borsboom J; Vasen HF; Van Asperen CJ; ; Schalken JA; Verhaegh GW; Kiemeney LA
    Urol Oncol; 2015 May; 33(5):202.e19-28. PubMed ID: 25746941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aptamer-antibody hybrid ELONA that uses hybridization chain reaction to detect a urinary biomarker EN2 for bladder and prostate cancer.
    Kim E; Kang M; Ban C
    Sci Rep; 2022 Jul; 12(1):11523. PubMed ID: 35798816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous antibodies against Engrailed-2 (EN2) protein in patients with prostate cancer.
    Annels NE; Simpson GR; Denyer M; McGrath SE; Falgari G; Killick E; Eeles R; Stebbing J; Pchejetski D; Cutress R; Murray N; Michael A; Pandha H
    Clin Exp Immunol; 2014 Aug; 177(2):428-38. PubMed ID: 24654775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasensitive electrochemical detection of engrailed-2 based on homeodomain-specific DNA probe recognition for the diagnosis of prostate cancer.
    Lee S; Jo H; Her J; Lee HY; Ban C
    Biosens Bioelectron; 2015 Apr; 66():32-8. PubMed ID: 25460878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered staining patterns and expression level of Engrailed-2 in benign prostatic hyperplasia and prostate Cancer predict prostatic disease progression.
    Li Q; Shi Y; Sa R; Hao J; Hu J; Xiao M; Wang C; Yan L; Qiao B; Chen G
    BMC Cancer; 2020 Jun; 20(1):555. PubMed ID: 32539763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer.
    Zhao F; Olkhov-Mitsel E; Kamdar S; Jeyapala R; Garcia J; Hurst R; Hanna MY; Mills R; Tuzova AV; O'Reilly E; Kelly S; Cooper C; ; Brewer D; Perry AS; Clark J; Fleshner N; Bapat B
    Clin Epigenetics; 2018 Nov; 10(1):147. PubMed ID: 30470249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker.
    Morgan R; Bryan RT; Javed S; Launchbury F; Zeegers MP; Cheng KK; James ND; Wallace DM; Hurst CD; Ward DG; Knowles MA; Pandha H
    Eur J Cancer; 2013 Jun; 49(9):2214-22. PubMed ID: 23434148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinically significant Prostate Cancer diagnosed using a urinary molecular biomarker-based risk score: two case reports.
    Minnee P; Hessels D; Schalken JA; Van Criekinge W
    BMC Urol; 2019 Nov; 19(1):124. PubMed ID: 31783839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.